Structural Basis of Pattern Recognition by Innate Immune Molecules

  • Eamon P. McGreal
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 653)


The importance of the innate immune system as a first line defence against pathogenic challenge has long been recognised. Over the last decade the identity of many of the key molecules mediating innate host defence have been clarified and a model of self/ nonself discrimination by families of pattern recognition receptors (PRRs) has emerged. Although a large amount of information is now available concerning the action of these innate immune molecules at the level of the cell and organism, litde is known about the molecular interface between pathogens and innate immune recognition molecules. In this chapter the molecular basis for innate immune discrimination of a wide variety of pathogen derived molecules is discussed in the context of the emerging literature.


Ligand Binding Innate Immune System Innate Host Defence Macrophage Mannose Receptor Pattern Recognition Molecule 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Berman HM, Westbrook J, Feng Z et al. The protein data bank. Nucleic Acids Res 2000; 28:235–242.PubMedGoogle Scholar
  2. 2.
    Janeway Jr CA. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989; 54(Pt 1):1–13.PubMedGoogle Scholar
  3. 3.
    Takahashi N, Takahashi Y, Putnam FW. Periodicity of leucine and tandem repetition of a 24-amino acid segment in the primary structure of leucine-rich alpha 2-glycoprotein of human serum. Proc Natl Acad Sci USA 1985; 82:1906–1910.PubMedGoogle Scholar
  4. 4.
    Schmitz F, Mages J, Heit A et al. Transcriptional activation induced in macrophages by Toll-like receptor (TLR) ligands: From expression profiling to a model of TLR signaling. Eur J Immunol 2004; 34:2863–2873.PubMedGoogle Scholar
  5. 5.
    Bell JK, Mullen GE, Leifer CA et al. Leucine-rich repeats and pathogen recognition in Toll-like receptors. Trends Immunol 2003; 24:528–533.PubMedGoogle Scholar
  6. 6.
    Papageorgiou AC, Shapiro R, Acharya KR. Molecular recognition of human angiogenin by placental ribonuclease inhibitor—an X-ray crystallographic study at 2.0 A resolution. EMBO J 1997; 16:5162–5177.PubMedGoogle Scholar
  7. 7.
    Schimmele B, Pluckthun A. Identification of a functional epitope of the Nogo receptor by a combinatorial approach using ribosome display. J Mol Biol 2005; 352:229–241.PubMedGoogle Scholar
  8. 8.
    Fan QR, Hendrickson WA. Structure of human follicle-stimulating hormone in complex with its receptor. Nature 2005; 433:269–277.PubMedGoogle Scholar
  9. 9.
    Bell JK, Botos I, Hall PR et al. The molecular structure of the Toll-like receptor 3 ligand-binding domain. Proc Natl Acad Sci USA 2005; 102:10976–10980.PubMedGoogle Scholar
  10. 10.
    Choe J, Kelker MS, Wilson IA. Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science 2005; 309:581–585.PubMedGoogle Scholar
  11. 11.
    Sun J, Duffy KE, Ranjith-Kumar CT et al. Structural and functional analyses of the human toll-like receptor 3: Role of glycosylation. J Biol Chem 2006; 281:11144–11151.PubMedGoogle Scholar
  12. 12.
    Mizel SB, West AP, Hantgan RR. Identification of a sequence in human toll-like receptor 5 required for the binding of Gram-negative flagellin. J Biol Chem 2003; 278:23624–23629.PubMedGoogle Scholar
  13. 13.
    Smith KD, Andersen-Nissen E, Hayashi F et al. Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat Immunol 2003; 4:1247–1253.PubMedGoogle Scholar
  14. 14.
    Kajava AV, Kobe B. Assessment of the ability to model proteins with leucine-rich repeats in light of the latest structural information. Protein Sci 2002; 11:1082–1090.PubMedGoogle Scholar
  15. 15.
    Jacchieri SG, Torquato R, Brentani RR. Structural study of binding of flagellin by Toll-like receptor 5. J Bacteriol 2003; 185:4243–4247.PubMedGoogle Scholar
  16. 16.
    Andersen-Nissen E, Smith KD, Strobe KL et al. Evasion of Toll-like receptor 5 by flagellated bacteria. Proc Natl Acad Sci USA 2005; 102:9247–9252.PubMedGoogle Scholar
  17. 17.
    Cornelie S, Hoebeke J, Schacht AM et al. Direct evidence that toll-like receptor 9 (TLR9) functionally binds plasmid DNA by specific cytosine-phosphate-guanine motif recognition. J Biol Chem 2004; 279:15124–15129.PubMedGoogle Scholar
  18. 18.
    Rutz M, Metzger J, Geliert T et al. Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence-and pH-dependent manner. Eur J Immunol 2004; 34:2541–2550.PubMedGoogle Scholar
  19. 19.
    Weber AN, Tauszig-Delamasure S, Hoffmann JA et al. Binding of the Drosophila cytokine Spatzle to Toll is direct and establishes signaling. Nat Immunol 2003; 4:794–800.PubMedGoogle Scholar
  20. 20.
    Wu CC, Lee J, Raz E et al. Necessity of oligonucleotide aggregation for toll-like receptor 9 activation. J Biol Chem 2004; 279:33071–33078.PubMedGoogle Scholar
  21. 21.
    Barton GM, Kagan JC, Medzhitov R. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol 2006; 7:49–56.PubMedGoogle Scholar
  22. 22.
    Hendrich B, Bird A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol 1998; 18:6538–6547.PubMedGoogle Scholar
  23. 23.
    Poltorak A, He X, Smirnova I et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 1998; 282:2085–2088.PubMedGoogle Scholar
  24. 24.
    Haziot A, Ferrero E, Kontgen F et al. Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice. Immunity 1996; 4:407–414.PubMedGoogle Scholar
  25. 25.
    Kim JI, Lee CJ, Jin MS et al. Crystal structure of CD14 and its implications for lipopolysaccharide signaling. J Biol Chem 2005; 280:11347–11351.PubMedGoogle Scholar
  26. 26.
    Cunningham MD, Shapiro RA, Seachord C et al. CD14 employs hydrophilic regions to “capture” lipopolysaccharides. J Immunol 2000; 164:3255–3263.PubMedGoogle Scholar
  27. 27.
    Dziarski R, Viriyakosol S, Kirkland TN et al. Soluble CD14 enhances membrane CD14-mediated responses to peptidoglycan: Structural requirements differ from those for responses to lipopolysaccharide. Infect Immun 2000; 68:5254–5260.PubMedGoogle Scholar
  28. 28.
    Juan TS, Hailman E, Kelley MJ et al. Identification of a lipopolysaccharide binding domain in CD14 between amino acids 57 and 64. J Biol Chem 1995; 270:5219–5224.PubMedGoogle Scholar
  29. 29.
    Viriyakosol S, Kirkland TN. A region of human CD14 required for lipopolysaccharide binding. J Biol Chem 1995; 270:361–368.PubMedGoogle Scholar
  30. 30.
    Muroi M, Tanamoto K. The polysaccharide portion plays an indispensable role in Salmonella lipopolysaccharide-induced activation of NF-kappaB through human toll-like receptor 4. Infect Immun 2002; 70:6043–6047.PubMedGoogle Scholar
  31. 31.
    Kitchens RL, Munford RS. Enzymatically deacylated lipopolysaccharide (LPS) can antagonize LPS at multiple sites in the LPS recognition pathway. J Biol Chem 1995; 270:9904–9910.PubMedGoogle Scholar
  32. 32.
    Wurfel MM, Monks BG, Ingalls RR et al. Targeted deletion of the lipopolysaccharide (LPS)-binding protein gene leads to profound suppression of LPS responses ex vivo, whereas in vivo responses remain intact. J Exp Med 1997; 186:2051–2056.PubMedGoogle Scholar
  33. 33.
    Jack RS, Fan X, Bernheiden M et al. Lipopolysaccharide-binding protein is required to combat a murine Gram-negative bacterial infection. Nature 1997; 389:742–745.PubMedGoogle Scholar
  34. 34.
    Tobias PS, Soldau K, Gegner JA et al. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J Biol Chem 1995; 270:10482–10488.PubMedGoogle Scholar
  35. 35.
    Yu B, Hailman E, Wright SD. Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids. J Clin Invest 1997; 99:315–324.PubMedGoogle Scholar
  36. 36.
    Beamer LJ, Carroll SF, Eisenberg D. The BPI/LBP family of proteins: A structural analysis of conserved regions. Protein Sci 1998; 7:906–914.PubMedGoogle Scholar
  37. 37.
    Beamer LJ, Carroll SF, Eisenberg D. The three-dimensional structure of human bactericidal/ permeability-increasing protein: Implications for understanding protein-lipopolysaccharide interactions. Biochem Pharmacol 1999; 57:225–229.PubMedGoogle Scholar
  38. 38.
    Dankesreiter S, Hoess A, Schneider-Mergener J et al. Synthetic endotoxin-binding peptides block endotoxin-triggered TNF-alpha production by macrophages in vitro and in vivo and prevent endotoxin-mediated toxic shock. J Immunol 2000; 164:4804–4811.PubMedGoogle Scholar
  39. 39.
    Taylor AH, Heavner G, Nedelman M et al. Lipopolysaccharide (LPS) neutralizing peptides reveal a lipid A binding site of LPS binding protein. J Biol Chem 1995; 270:17934–17938.PubMedGoogle Scholar
  40. 40.
    Lamping N, Hoess A, Yu B et al. Effects of site-directed mutagenesis of basic residues (Arg 94, Lys 95, Lys 99) of lipopolysaccharide (LPS)-binding protein on binding and transfer of LPS and subsequent immune cell activation. J Immunol 1996; 157:4648–4656.PubMedGoogle Scholar
  41. 41.
    Hoess A, Schneider-Mergener J, Liddington RC. Identification of the LPS-binding domain of an endotoxin neutralising protein, Limulus anti-LPS factor. Prog Clin Biol Res 1995; 392:327–337.PubMedGoogle Scholar
  42. 42.
    Hoess A, Watson S, Siber GR et al. Crystal structure of an endotoxin-neutralizing protein from the horseshoe crab, Limulus anti-LPS factor, at 1.5 A resolution. EMBO J 1993; 12:3351–3356.PubMedGoogle Scholar
  43. 43.
    Viriyakosol S, Tobias PS, Kitchens RL et al. MD-2 binds to bacterial lipopolysaccharide. J Biol Chem 2001; 276:38044–38051.PubMedGoogle Scholar
  44. 44.
    Nagai Y, Akashi S, Nagafuku M et al. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol 2002; 3:667–672.PubMedGoogle Scholar
  45. 45.
    Gruber A, Mancek M, Wagner H et al. Structural model of MD-2 and functional role of its basic amino acid clusters involved in cellular lipopolysaccharide recognition. J Biol Chem 2004; 279:28475–28482.PubMedGoogle Scholar
  46. 46.
    Inohara N, Nunez G. ML — A conserved domain involved in innate immunity and lipid metabolism. Trends Biochem Sci 2002; 27:219–221.PubMedGoogle Scholar
  47. 47.
    Re F, Strominger JL. Separate functional domains of human MD-2 mediate Toll-like receptor 4-binding and lipopolysaccharide responsiveness. J Immunol 2003; 171:5272–5276.PubMedGoogle Scholar
  48. 48.
    Hajjar AM, Ernst RK, Tsai JH et al. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat Immunol 2002; 3:354–359.PubMedGoogle Scholar
  49. 49.
    Schroder NW, Schumann RR. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 2005; 5:156–164.PubMedGoogle Scholar
  50. 50.
    Fujimoto T, Yamazaki S, Eto-Kimura A et al. The amino-terminal region of toll-like receptor 4 is essential for binding to MD-2 and receptor translocation to the cell surface. J Biol Chem 2004; 279:47431–47437.PubMedGoogle Scholar
  51. 51.
    Ozinsky A, Underhill DM, Fontenot JD et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA 2000; 97:13766–13771.PubMedGoogle Scholar
  52. 52.
    Muhlradt PF, Kiess M, Meyer H et al. Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration. J Exp Med 1997; 185:1951–1958.PubMedGoogle Scholar
  53. 53.
    Muhlradt PF, Kiess M, Meyer H et al. Structure and specific activity of macrophage-stimulating lipopeptides from Mycoplasma hyorhinis. Infect Immun 1998; 66:4804–4810.PubMedGoogle Scholar
  54. 54.
    Shibata K, Hasebe A, Into T et al. The N-terminal lipopeptide of a 44-kDa membrane-bound lipoprotein of Mycoplasma salivarium is responsible for the expression of intercellular adhesion molecule-1 on the cell surface of normal human gingival fibroblasts. J Immunol 2000; 165:6538–6544.PubMedGoogle Scholar
  55. 55.
    Takeuchi O, Sato S, Horiuchi T et al. Cutting edge: Role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 2002; 169:10–14.PubMedGoogle Scholar
  56. 56.
    Wyllie DH, Kiss-Toth E, Visintin A et al. Evidence for an accessory protein function for Toll-like receptor 1 in anti-bacterial responses. J Immunol 2000; 165:7125–7132.PubMedGoogle Scholar
  57. 57.
    Takeuchi O, Kawai T, Muhlradt PF et al. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol 2001; 13:933–940.PubMedGoogle Scholar
  58. 58.
    Massari P, Visintin A, Gunawardana J et al. Meningococcal porin PorB binds to TLR2 and requires TLR1 for signaling. J Immunol 2006; 176:2373–2380.PubMedGoogle Scholar
  59. 59.
    Omueti KO, Beyer JM, Johnson CM et al. Domain exchange between human toll-like receptors 1 and 6 reveals a region required for lipopeptide discrimination. J Biol Chem 2005; 280:36616–36625.PubMedGoogle Scholar
  60. 60.
    Akira S. Mammalian Toll-like receptors. Curr Opin Immunol 2003; 15:5–11.PubMedGoogle Scholar
  61. 61.
    Himmelreich R, Hilbert H, Plagens H et al. Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae. Nucleic Acids Res 1996; 24:4420–4449.PubMedGoogle Scholar
  62. 62.
    Yamamoto M, Sato S, Hemmi H et al. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 2002; 420:324–329.PubMedGoogle Scholar
  63. 63.
    Brown GD. Dectin-1: A signalling non-TLR pattern-recognition receptor. Nat Rev Immunol 2006; 6:33–43.PubMedGoogle Scholar
  64. 64.
    Inohara, Chamaillard, McDonald C et al. NOD-LRR proteins: Role in host-microbial interactions and inflammatory disease. Annu Rev Biochem 2005; 74:355–383.PubMedGoogle Scholar
  65. 65.
    Petrilli V, Papin S, Tschopp J. The inflammasome. Curr Biol 2005; 15:R581.PubMedGoogle Scholar
  66. 66.
    Gumucio DL, Diaz A, Schaner P et al. Cesena. Fire and ICE: The role of pyrin domain-containing proteins in inflammation and apoptosis. Clin Exp Rheumatol 2002; 20:S45–S53.PubMedGoogle Scholar
  67. 67.
    Bouchier-Hayes L, Martin SJ. CARD games in apoptosis and immunity. EMBO Rep 2002; 3:616–621.PubMedGoogle Scholar
  68. 68.
    Girardin SE, Travassos LH, Herve M et al. Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J Biol Chem 2003; 278:41702–41708.PubMedGoogle Scholar
  69. 69.
    Girardin SE, Boneca IG, Carneiro LA et al. Nod1 detects a unique muropeptide from Gram-negative bacterial peptidoglycan. Science 2003; 300:1584–1587.PubMedGoogle Scholar
  70. 70.
    Chamaillard M, Hashimoto M, Horie Y et al. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol 2003; 4:702–707.PubMedGoogle Scholar
  71. 71.
    Magalhaes JG, Philpott DJ, Nahori MA et al. Murine Nod1 but not its human orthologue mediates innate immune detection of tracheal cytotoxin. EMBO Rep 2005; 6:1201–1207.PubMedGoogle Scholar
  72. 72.
    Yanagihara Y, Kamisango K, Yasuda S et al. Chemical compositions of cell walls and polysaccharide fractions of spirochetes. Microbiol Immunol 1984; 28:535–544.PubMedGoogle Scholar
  73. 73.
    Ellis J, Dodds P, Pryor T. Structure, function and evolution of plant disease resistance genes. Curr Opin Plant Biol 2000; 3:278–284.PubMedGoogle Scholar
  74. 74.
    Girardin SE, Jehanno M, Mengin-Lecreulx D et al. Identification of the critical residues involved in peptidoglycan detection by Nod1. J Biol Chem 2005; 280:38648–38656.PubMedGoogle Scholar
  75. 75.
    Tanabe T, Chamaillard M, Ogura Y et al. Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition. EMBO J 2004; 23:1587–1597.PubMedGoogle Scholar
  76. 76.
    Cario E. Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2. Gut 2005; 54:1182–1193.PubMedGoogle Scholar
  77. 77.
    Kanneganti TD, Ozoren N, Body-Malapel M et al. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 2006; 440:233–236.PubMedGoogle Scholar
  78. 78.
    Mariathasan S, Weiss DS, Newton K et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006; 440:228–232.PubMedGoogle Scholar
  79. 79.
    Martinon F, Petrilli V, Mayor A et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006; 440:237–241.PubMedGoogle Scholar
  80. 80.
    Franchi L, Amer A, Body-Malapel M et al. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat Immunol 2006; 7:576–582.PubMedGoogle Scholar
  81. 81.
    Miao EA, Alpuche-Aranda CM, Dors M et al. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat Immunol 2006; 7:569–575.PubMedGoogle Scholar
  82. 82.
    Marathe R, Dinesh-Kumar SP. Plant defense: One post, multiple guards! Mol Cell 2003; 11:284–286.PubMedGoogle Scholar
  83. 83.
    Matzinger P. The danger model: A renewed sense of self. Science 2002; 296:301–305.PubMedGoogle Scholar
  84. 84.
    Coaker G, Falick A, Staskawicz B. Activation of a phytopathogenic bacterial effector protein by a eukaryotic cyclophilin. Science 2005; 308:548–550.PubMedGoogle Scholar
  85. 85.
    Rooney HC, Van’t Klooster JW, van der Hoorn RA et al. Cladosporium Avr2 inhibits tomato Rcr3 protease required for Cf-2-dependent disease resistance. Science 2005; 308:1783–1786.PubMedGoogle Scholar
  86. 86.
    Ligoxygakis P, Pelte N, Hoffmann JA et al. Activation of Drosophila Toll during fungal infection by a blood serine protease. Science 2002; 297:114–116.PubMedGoogle Scholar
  87. 87.
    Thiel S, Vorup-Jensen T, Stover CM et al. A second serine protease associated with mannan-binding lectin that activates complement. Nature 1997; 386:506–510.PubMedGoogle Scholar
  88. 88.
    McGreal EP, Martinez-Pomares L, Gordon S. Divergent roles for C-type lectins expressed by cells of the innate immune system. Mol Immunol 2004; 41:1109–1121.PubMedGoogle Scholar
  89. 89.
    Bezouska K, Crichlow GV, Rose JM et al. Evolutionary conservation of intron position in a sub-family of genes encoding carbohydrate-recognition domains. J Biol Chem 1991; 266:11604–11609.PubMedGoogle Scholar
  90. 90.
    Weis WI, Drickamer K, Hendrickson WA. Structure of a C-type mannose-binding protein complexed with an oligosaccharide. Nature 1992; 360:127–134.PubMedGoogle Scholar
  91. 91.
    Appelmelk BJ, van Die I, van Vliet SJ et al. Cutting edge: Carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J Immunol 2003; 170:1635–1639.PubMedGoogle Scholar
  92. 92.
    Cambi A, Gijzen K, de Vries JM et al. The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells. Eur J Immunol 2003; 33:532–538.PubMedGoogle Scholar
  93. 93.
    Meyer S, van Liempt E, Imberty A et al. DC-SIGN mediates binding of dendritic cells to authentic pseudo-LewisY glycolipids of Schistosoma mansoni cercariae, the first parasite-specific ligand of DC-SIGN. J Biol Chem 2005; 280:37349–37359.PubMedGoogle Scholar
  94. 94.
    Feinberg H, Mitchell DA, Drickamer K et al. Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR. Science 2001; 294:2163–2166.PubMedGoogle Scholar
  95. 95.
    Guo Y, Feinberg H, Conroy E et al. Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR. Nat Struct Mol Biol 2004; 11:591–598.PubMedGoogle Scholar
  96. 96.
    Drickamer K. Engineering galactose-binding activity into a C-type mannose-binding protein. Nature 1992; 360:183–186.PubMedGoogle Scholar
  97. 97.
    Iobst ST, Drickamer K. Binding of sugar ligands to Ca(2+)-dependent animal lectins. II. Generation of high-affinity galactose binding by site-directed mutagenesis. J Biol Chem 1994; 269:15512–15519.PubMedGoogle Scholar
  98. 98.
    Sheriff S, Chang CY, Ezekowitz RA. Human mannose-binding protein carbohydrate recognition domain trimerizes through a triple alpha-helical coiled-coil. Nat Struct Biol 1994; 1:789–794.PubMedGoogle Scholar
  99. 99.
    Weis WI, Drickamer K. Trimeric structure of a C-type mannose-binding protein. Structure 1994; 2:1227–1240.PubMedGoogle Scholar
  100. 100.
    Feinberg H, Guo Y, Mitchell DA et al. Extended neck regions stabilize tetramers of the receptors DC-SIGN and DC-SIGNR. J Biol Chem 2005; 280:1327–1335.PubMedGoogle Scholar
  101. 101.
    Mitchell DA, Fadden AJ, Drickamer K. A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR: Subunit organization and binding to multivalent ligands. J Biol Chem 2001; 276:28939–28945.PubMedGoogle Scholar
  102. 102.
    Snyder GA, Ford J, Torabi-Parizi P et al. Characterization of DC-SIGN/R interaction with human immunodeficiency virus type 1 gp120 and ICAM molecules favors the receptor’s role as an antigen-capturing rather than an adhesion receptor. J Virol 2005; 79:4589–4598.PubMedGoogle Scholar
  103. 103.
    Ashwell G, Harford J. Carbohydrate-specific receptors of the liver. Annu Rev Biochem 1982; 51:531–554.PubMedGoogle Scholar
  104. 104.
    Park EI, Manzella SM, Baenziger JU. Rapid clearance of sialylated glycoproteins by the asialoglycoprotein receptor. J Biol Chem 2003; 278:4597–4602.PubMedGoogle Scholar
  105. 105.
    Park EI, Mi Y, Unverzagt C et al. The asialoglycoprotein receptor clears glycoconjugates terminating with sialic acid alpha 2,6GalNAc. Proc Natl Acad Sci USA 2005; 102:17125–17129.PubMedGoogle Scholar
  106. 106.
    Yamamoto K, Ishida C, Shinohara Y et al. Interaction of immobilized recombinant mouse C-type macrophage lectin with glycopeptides and oligosaccharides. Biochemistry 1994; 33:8159–8166.PubMedGoogle Scholar
  107. 107.
    Yuita H, Tsuiji M, Tajika Y et al. Retardation of removal of radiation-induced apoptotic cells in developing neural tubes in macrophage galactose-type C-type lectin-1-deficient mouse embryos. Glycobiology 2005; 15:1368–1375.PubMedGoogle Scholar
  108. 108.
    Bilyy RO, Antonyuk VO, Stoika RS. Cytochemical study of role of alpha-d-mannose-and beta-d-galactose-containing glycoproteins in apoptosis. J Mol Histol 2004; 35:829–838.PubMedGoogle Scholar
  109. 109.
    Rapoport E, Khaidukov S, Baidina O et al. Involvement of the Galbetal — 3GalNAcbeta structure in the recognition of apoptotic bodies by THP-1 cells. Eur J Cell Biol 2003; 82:295–302.PubMedGoogle Scholar
  110. 110.
    van Vliet SJ, van Liempt E, Saeland E et al. Carbohydrate profiling reveals a distinctive role for the C-type lectin MGL in the recognition of helminth parasites and tumor antigens by dendritic cells. Int Immunol 2005; 17:661–669.PubMedGoogle Scholar
  111. 111.
    Leteux C, Chai W, Loveless RW et al. The cysteine-rich domain of the macrophage mannose receptor is a multispecific lectin that recognizes chondroitin sulfates A and B and sulfated oligosaccharides of blood group Lewis(a) and Lewis(x) types in addition to the sulfated N-glycans of lutropin. J Exp Med 2000; 191:1117–1126.PubMedGoogle Scholar
  112. 112.
    Martinez-Pomares L, Crocker PR, Da Silva R et al. Cell-specific glycoforms of sialoadhesin and CD45 are counter-receptors for the cysteine-rich domain of the mannose receptor. J Biol Chem 1999; 274:35211–35218.PubMedGoogle Scholar
  113. 113.
    Martinez-Pomares L, Wienke D, Stillion R et al. Carbohydrate-independent recognition of collagens by the macrophage mannose receptor. Eur J Immunol 2006; 36:1074–1082.PubMedGoogle Scholar
  114. 114.
    Downing I, Koch C, Kilpatrick DC. Immature dendritic cells possess a sugar-sensitive receptor for human mannan-binding lectin. Immunology 2003; 109:360–364.PubMedGoogle Scholar
  115. 115.
    Downing I, MacDonald SL, Turner ML et al. Detection of an autologous ligand for mannan-binding lectin on human B lymphocytes. Scand J Immunol 2005; 62:507–514.PubMedGoogle Scholar
  116. 116.
    Arnold JN, Wormald MR, Suter DM et al. Human serum IgM glycosylation: Identification of glycoforms that can bind to mannan-binding lectin. J Biol Chem 2005; 280:29080–29087.PubMedGoogle Scholar
  117. 117.
    Roos A, Bouwman LH, van Gijlswijk-Janssen DJ et al. Human IgA activates the complement system via the mannan-binding lectin pathway. J Immunol 2001; 167:2861–2868.PubMedGoogle Scholar
  118. 118.
    Malhotra R, Wormald MR, Rudd PM et al. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med 1995; 1:237–243.PubMedGoogle Scholar
  119. 119.
    Arnold JN, Wallis R, Willis AC et al. Interaction of mannan binding lectin with alpha2 macroglobulin via exposed oligomannose glycans: A conserved feature of the thiol ester protein family? J Biol Chem 2006; 281:6955–6963.PubMedGoogle Scholar
  120. 120.
    Nauta AJ, Raaschou-Jensen N, Roos A et al. Mannose-binding lectin engagement with late apoptotic and necrotic cells. Eur J Immunol 2003; 33:2853–2863.PubMedGoogle Scholar
  121. 121.
    Ogden CA, deCathelineau A, Hoffmann PR et al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 2001; 194:781–795.PubMedGoogle Scholar
  122. 122.
    Stuart LM, Takahashi K, Shi L et al. Mannose-binding lectin-deficient mice display defective apoptotic cell clearance but no autoimmune phenotype. J Immunol 2005; 174:3220–3226.PubMedGoogle Scholar
  123. 123.
    Schagat TL, Woffbrd JA, Wright JR. Surfactant protein A enhances alveolar macrophage phagocytosis of apoptotic neutrophils. J Immunol 2001; 166:2727–2733.PubMedGoogle Scholar
  124. 124.
    Vandivier RW, Ogden CA, Fadok VA et al. Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: Calreticulin and CD91 as a common collectin receptor complex. J Immunol 2002; 169:3978–3986.PubMedGoogle Scholar
  125. 125.
    Palaniyar N, Clark H, Nadesalingam J et al. Surfactant protein D binds genomic DNA and apoptotic cells, and enhances their clearance, in vivo. Ann N Y Acad Sci 2003; 1010:471–475.PubMedGoogle Scholar
  126. 126.
    Palaniyar N, Nadesalingam J, Clark H et al. Nucleic acid is a novel ligand for innate, immune pattern recognition collectins surfactant proteins A and D and mannose-binding lectin. J Biol Chem 2004; 279:32728–32736.PubMedGoogle Scholar
  127. 127.
    Jiang H, Cooper B, Robey FA et al. DNA binds and activates complement via residues 14–26 of the human C1q A chain. J Biol Chem 1992; 267:25597–25601.PubMedGoogle Scholar
  128. 128.
    Geijtenbeek TB, Torensma R, van Vliet SJ et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000; 100:575–585.PubMedGoogle Scholar
  129. 129.
    Geijtenbeek TB, Krooshoop DJ, Bleijs DA et al. DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking. Nat Immunol 2000; 1:353–357.PubMedGoogle Scholar
  130. 130.
    Su SV, Hong P, Baik S et al. DC-SIGN binds to HIV-1 glycoprotein 120 in a distinct but overlapping fashion compared with ICAM-2 and ICAM-3. J Biol Chem 2004; 279:19122–19132.PubMedGoogle Scholar
  131. 131.
    Koppel EA, Ludwig IS, Hernandez MS et al. Identification of the mycobacterial carbohydrate structure that binds the C-type lectins DC-SIGN, L-SIGN and SIGNR1. Immunobiology 2004; 209:117–127.PubMedGoogle Scholar
  132. 132.
    McGreal EP, Rosas M, Brown GD et al. The carbohydrate-recognition domain of Dectin-2 is a C-type lectin with specificity for high mannose. Glycobiology 2006; 16:422–430.PubMedGoogle Scholar
  133. 133.
    Powlesland AS, Ward EM, Sadhu SK et al. Widely divergent biochemical properties of the complete set of mouse DC-SIGN-related proteins. J Biol Chem 2006; 281:20440–20449.PubMedGoogle Scholar
  134. 134.
    Takahara K, Yashima Y, Omatsu Y et al. Functional comparison of the mouse DC-SIGN, SIGNR1, SIGNR3 and Langerin, C-type lectins. Int Immunol 2004; 16:819–829.PubMedGoogle Scholar
  135. 135.
    Taylor PR, Brown GD, Herre J et al. The role of SIGNR1 and the beta-glucan receptor (dectin-1) in the nonopsonic recognition of yeast by specific macrophages. J Immunol 2004; 172:1157–1162.PubMedGoogle Scholar
  136. 136.
    Garlanda C, Bottazzi B, Bastone A et al. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 2005; 23:337–366.PubMedGoogle Scholar
  137. 137.
    Emsley J, White HE, O’Hara BP et al. Structure of pentameric human serum amyloid P component. Nature 1994; 367:338–345.PubMedGoogle Scholar
  138. 138.
    Garlanda C, Hirsch E, Bozza S et al. Nonredundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature 2002; 420:182–186.PubMedGoogle Scholar
  139. 139.
    Varani S, Elvin JA, Yan C et al. Knockout of pentraxin 3, a downstream target of growth differentiation factor-9, causes female subfertility. Mol Endocrinol 2002; 16:1154–1167.PubMedGoogle Scholar
  140. 140.
    Rovere P, Peri G, Fazzini F et al. The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells. Blood 2000; 96:4300–4306.PubMedGoogle Scholar
  141. 141.
    van Rossum AP, Fazzini F, Limburg PC et al. The prototypic tissue pentraxin PTX3, in contrast to the short pentraxin serum amyloid P, inhibits phagocytosis of late apoptotic neutrophils by macrophages. Arthritis Rheum 2004; 50:2667–2674.PubMedGoogle Scholar
  142. 142.
    Roumenina LT, Ruseva MM, Zlatarova A et al. Interaction of C1q with IgG1, C-reactive protein and pentraxin 3: Mutational studies using recombinant globular head modules of human C1q A, B, and C chains. Biochemistry 2006; 45:4093–4104.PubMedGoogle Scholar
  143. 143.
    Brown GD, Gordon S. Immune recognition: A new receptor for beta-glucans. Nature 2001; 413:36–37.PubMedGoogle Scholar
  144. 144.
    Underhill DM, Ozinsky A, Hajjar AM et al. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 1999; 401:811–815.PubMedGoogle Scholar
  145. 145.
    Natarajan K, Dimasi N, Wang J et al. Structure and function of natural killer cell receptors: Multiple molecular solutions to self, nonself discrimination. Annu Rev Immunol 2002; 20:853–885.PubMedGoogle Scholar
  146. 146.
    Ariizumi K, Shen GL, Shikano S et al. Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractive cDNA cloning. J Biol Chem 2000; 275:20157–20167.PubMedGoogle Scholar
  147. 147.
    Adachi Y, Ishii T, Ikeda Y et al. Characterization of beta-glucan recognition site on C-type lectin, dectin 1. Infect Immun 2004; 72:4159–4171.PubMedGoogle Scholar
  148. 148.
    Ichijo H, Hellman U, Wernstedt C et al. Molecular cloning and characterization of ficolin, a multimeric protein with fibrinogen-and collagen-like domains. J Biol Chem 1993; 268:14505–14513.PubMedGoogle Scholar
  149. 149.
    Fujita T, Matsushita M, Endo Y. The lectin-complement pathway—its role in innate immunity and evolution. Immunol Rev 2004; 198:185–202.PubMedGoogle Scholar
  150. 150.
    Frederiksen PD, Thiel S, Larsen CB et al. M-ficolin, an innate immune defence molecule, binds patterns of acetyl groups and activates complement. Scand J Immunol 2005; 62:462–473.PubMedGoogle Scholar
  151. 151.
    Krarup A, Thiel S, Hansen A et al. L-ficolin is a pattern recognition molecule specific for acetyl groups. J Biol Chem 2004; 279:47513–47519.PubMedGoogle Scholar
  152. 152.
    Kairies N, Beisel HG, Fuentes-Prior P et al. The 2.0-A crystal structure of tachylectin 5A provides evidence for the common origin of the innate immunity and the blood coagulation systems. Proc Natl Acad Sci USA 2001; 98:13519–13524.PubMedGoogle Scholar
  153. 153.
    Krarup A, Sorensen UB, Matsushita M et al. Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin. Infect Immun 2005; 73:1052–1060.PubMedGoogle Scholar
  154. 154.
    Lynch NJ, Roscher S, Hartung T et al. L-ficolin specifically binds to lipoteichoic acid, a cell wall constituent of Gram-positive bacteria, and activates the lectin pathway of complement. J Immunol 2004; 172:1198–1202.PubMedGoogle Scholar
  155. 155.
    Jensen ML, Honore C, Hummelshoj T et al. Ficolin-2 recognizes DNA and participates in the clearance of dying host cells. Mol Immunol 2006.Google Scholar
  156. 156.
    Kuraya M, Ming Z, Liu X et al. Specific binding of L-ficolin and H-ficolin to apoptotic cells leads to complement activation. Immunobiology 2005; 209:689–697.PubMedGoogle Scholar
  157. 157.
    Ma YG, Cho MY, Zhao M et al. Human mannose-binding lectin and L-ficolin function as specific pattern recognition proteins in the lectin activation pathway of complement. J Biol Chem 2004; 279:25307–25312.PubMedGoogle Scholar
  158. 158.
    Matsushita M, Kuraya M, Hamasaki N et al. Activation of the lectin complement pathway by H-ficolin (Hakata antigen). J Immunol 2002; 168:3502–3506.PubMedGoogle Scholar
  159. 159.
    Holmskov U, Thiel S, Jensenius JC. Collections and ficolins: Humoral lectins of the innate immune defense. Annu Rev Immunol 2003; 21:547–578.PubMedGoogle Scholar
  160. 160.
    Taylor PR, Martinez-Pomares L, Stacey M et al. Macrophage receptors and immune recognition. Annu Rev Immunol 2005; 23:901–944.PubMedGoogle Scholar
  161. 161.
    Taylor ME, Bezouska K, Drickamer K. Contribution to ligand binding by multiple carbohydrate-recognition domains in the macrophage mannose receptor. J Biol Chem 1992; 267:1719–1726.PubMedGoogle Scholar
  162. 162.
    Palma AS, Feizi T, Zhang Y et al. Ligands for the beta-glucan receptor, Dectin-1, assigned using “designer” microarrays of oligosaccharide probes (neoglycolipids) generated from glucan polysaccharides. J Biol Chem 2006; 281:5771–5779.PubMedGoogle Scholar
  163. 163.
    Eckmann L. Innate immunity and mucosal bacterial interactions in the intestine. Curr Opin Gastroenterol 2004; 20:82–88.PubMedGoogle Scholar
  164. 164.
    Zarember KA, Godowski PJ. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 2002; 168:554–561.PubMedGoogle Scholar
  165. 165.
    Greene CM, Carroll TP, Smith SG et al. TLR-induced inflammation in cystic fibrosis and noncystic fibrosis airway epithelial cells. J Immunol 2005; 174:1638–1646.PubMedGoogle Scholar
  166. 166.
    Heumann D, Lauener R, Ryffel B. The dual role of LBP and CD14 in response to Gram-negative bacteria or Gram-negative compounds. J Endotoxin Res 2003; 9:381–384.PubMedGoogle Scholar
  167. 167.
    Devitt A, Moffatt OD, Raykundalia C et al. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 1998; 392:505–509.PubMedGoogle Scholar
  168. 168.
    Kawai T, Akira S. Pathogen recognition with Toll-like receptors. Curr Opin Immunol 2005; 17:338–344.PubMedGoogle Scholar
  169. 169.
    Hermann C, Spreitzer I, Schroder NW et al. Cytokine induction by purified lipoteichoic acids from various bacterial species—role of LBP, sCD14, CD14 and failure to induce IL-12 and subsequent IFN-gamma release. Eur J Immunol 2002; 32:541–551.PubMedGoogle Scholar
  170. 170.
    Bottazzi B, Bastone A, Doni A et al. The long pentraxin PTX3 as a link among innate immunity, inflammation, and female fertility. J Leukoc Biol 2006; 79:909–912.PubMedGoogle Scholar
  171. 171.
    Jeannin P, Bottazzi B, Sironi M et al. Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors. Immunity 2005; 22:551–560.PubMedGoogle Scholar
  172. 172.
    Bottazzi B, Vouret-Craviari V, Bastone A et al. Multimer formation and ligand recognition by the long pentraxin PTX3: Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. J Biol Chem 1997; 272:32817–32823.PubMedGoogle Scholar

Copyright information

© Landes Bioscience and Springer Science+Business Media 2009

Authors and Affiliations

  • Eamon P. McGreal
    • 1
  1. 1.Department of Child HealthCardiff University School of MedicineHeath Park, CardiffUK

Personalised recommendations